what is glp 1 agonist drugs glp-1_analogs [TUSOM GLP-1 Medications for Weight Loss:

Some participants achieved 20% weight loss when treatment was continued

Clinical evidence Evidence among individuals with diabetes Major cardiovascular outcome trials of GLP-1 RAs in individuals with T2DM have consistently demonstrated modest reductions in SBP (Table 1)

In summary, GLP-1 or GLP-1RA treatment can make a positive impact on reducing the impact of hypertension in affected patients (Figure 1)

For example, the Krispy Kreme stock was downgraded by several investment banks from buy to hold, with the stock price dropping c.14% in the immediate wake of the SELECT trial announcement in August 2023 (from $14.40 to $12.43) due to the uncertain impact that the rise in weight-loss drugs will have on the future sales of the business

Relationship of abdominal obesity with cardiovascular disease, diabetes and hyperlipidaemia in Spain

22,23 In the liver, GLP-1RAs can also decrease hepatic gluconeogenesis and enhance glucose uptake, which can improve circulating glucose levels